Summary: TENNOR THERAP-B (06872) reported Operating profit of -118.67M(-52.14%); Net profit attributable to owners of -153.24M(-5.01%).
ReportedYoY
Prior YearYoY
Operating profitDown YoY
-118.67M52.14%
-78.00M36.32%
Net profit attributable to ownersDown YoY
-153.24M5.01%
-145.93M23.93%
Operating profit
ReportedUnit: CNY
Net profit attributable to owners
ReportedUnit: CNY
FY2026 Interim Report
Reporting period: 2026.01.01-2026.06.30
Summary: TENNOR THERAP-B (06872) reported Revenue of 0; Operating profit of -64.57M(-46.92%); Net profit attributable to owners of -64.25M(+17.81%).
ReportedYoY
Prior YearYoY
Revenue
0--
0--
Operating profitDown YoY
-64.57M46.92%
-43.95M--
Net profit attributable to ownersUp YoY
-64.25M17.81%
-78.17M--
Revenue
ReportedUnit: CNY
Operating profit
ReportedUnit: CNY
Net profit attributable to owners
ReportedUnit: CNY
ROEYoY
Unit: CNY
FY 2023
FY 2024
FY 2025
Profitability
(YoY)
Growth
(YoY)
Asset Quality
(YoY)
Cash Generation
(YoY)
Attributable profit growthYoY
Unit: CNY
H1 2025
H1 2026
Growth
(YoY)
Asset Quality
(YoY)
Cash Generation
(YoY)
Other income and gainsYoY
Unit: CNY
FY 2023
FY 2024
FY 2025
Revenue
(YoY)
Expenses
(YoY)
Interest
(YoY)
Profit
(YoY)
RevenueYoY
Unit: CNY
H1 2025
H1 2026
Revenue
(YoY)
Interest
(YoY)
Income Tax
(YoY)
Profit
(YoY)
Cash and cash equivalentsYoY
Unit: CNY
FY 2023
FY 2024
FY 2025
Assets
(YoY)
Liabilities
(YoY)
Equity
(YoY)
Cash and cash equivalentsYoY
Unit: CNY
H1 2025
H1 2026
Assets
(YoY)
Liabilities
(YoY)
Equity
(YoY)
Net cash from operating activitiesYoY
Unit: CNY
FY 2023
FY 2024
FY 2025
Operating Cash Flow
(YoY)
Investing Cash Flow
(YoY)
Financing Cash Flow
(YoY)
Net Change in Cash
(YoY)
Net cash from operating activitiesYoY
Unit: CNY
H1 2025
H1 2026
Operating Cash Flow
(YoY)
Investing Cash Flow
(YoY)
Financing Cash Flow
(YoY)
Net Change in Cash
(YoY)
Buybacks
Total repurchased
1.05M HKD
Shares repurchased
11.15K
Buyback days
1
Cumulative since 2026-10-27 (from HKEXnews next-day disclosure returns; earlier records are not included).
Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.
About this page
This page shows TENNOR THERAP-B (06872) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.